Description

1-Imidazolidinecarboxylic acid, 5-[[3-bromo-5-[(diethoxyphosphinyl)methyl]phenyl]methyl]-2-(1,1-dimethylethyl)-3-methyl-4-oxo-, 1,1-dimethylethyl ester, (2S-trans)- (9CI) is a sophisticated chiral organophosphorus compound with a complex molecular architecture. This high-value specialty chemical serves as a critical building block or intermediate in advanced synthetic chemistry, enabling the development of novel active ingredients. It is primarily needed by research and development teams in the pharmaceutical and agrochemical industries, where its unique structure facilitates the creation of targeted molecules with specific biological activities. The compound is supplied under strict quality control to ensure batch-to-batch consistency for demanding applications.

Application

This advanced chemical intermediate is designed for specialized synthetic pathways. Its primary applications include:

• Pharmaceutical Intermediate: A key chiral precursor in the synthesis of novel drug candidates, particularly for targeted therapies.
• Agrochemical Research: Used in the development of next-generation pesticides or herbicides, leveraging its organophosphorus moiety.
• Chemical Synthesis Building Block: Employed in complex organic synthesis for constructing molecules with specific stereochemistry and functional groups.
• Ligand or Catalyst Development: Potential use in the design of chiral ligands or organocatalysts for asymmetric synthesis.
• Life Science Research: Utilized in biochemical and pharmacological research to study enzyme interactions or structure-activity relationships (SAR).

Basic Information

Item	Details
Product Name	1-Imidazolidinecarboxylic acid, 5-[[3-bromo-5-[(diethoxyphosphinyl)methyl]phenyl]methyl]-2-(1,1-dimethylethyl)-3-methyl-4-oxo-, 1,1-dimethylethyl ester, (2S-trans)- (9CI)
CAS No.	174575-06-5
Molecular Formula	C26H40BrNO6P
Molecular Weight	582.48 g/mol
Synonyms	tert-Butyl (2S,5R)-5-((3-bromo-5-((diethoxyphosphoryl)methyl)benzyl)-2-tert-butyl-3-methyl-4-oxoimidazolidine-1-carboxylate; (2S,5R)-1-(tert-Butoxycarbonyl)-5-[(3-bromo-5-{[(diethoxyphosphoryl)methyl]phenyl}methyl]-2-tert-butyl-3-methyl-4-imidazolidinone; CAS 174575-06-5; (2S-trans)-1,1-Dimethylethyl 5-[[3-bromo-5-[(diethoxyphosphinyl)methyl]phenyl]methyl]-2-(1,1-dimethylethyl)-3-methyl-4-oxo-1-imidazolidinecarboxylate; BOC-protected bromo-phosphonate imidazolidinone derivative
EINECS	Contact for details

Quality Control

Our 1-Imidazolidinecarboxylic acid derivative is manufactured under a strict quality management system. Every batch undergoes comprehensive analytical testing, including HPLC, NMR, and chiral purity analysis, to ensure it meets the high standards required for research and development. A detailed Certificate of Analysis (COA) is provided with each shipment, confirming identity, purity, and critical specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed under an inert atmosphere (e.g., nitrogen or argon) after opening to prevent degradation. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Chiral Purity (Chiral HPLC)	≥ 98.0% ee
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.